How Wearable Patches Are Tracking Drug Levels in Real Time

Episode 124 of The Wearable Tech Podcast explores a new frontier in wearable health: continuous drug monitoring patches. Lucas and Luna break down how a thin, skin-adherent sensor developed at Stanford and now licensed to a startup called Biolinq can measure medication concentrations in interstitial fluid every few minutes—no blood draw required. They discuss the specific example of a lithium monitoring patch for bipolar disorder patients, where staying in a narrow therapeutic window matters enormously. Lucas explains the electrochemistry behind the sensor: an enzyme-coated electrode that oxidizes the drug molecule and produces a current proportional to its concentration. Luna raises the practical questions: Will insurance cover it? Is it comfortable to wear for a week? They also touch on the broader implications for clinical trials and personalized dosing, including a 2025 pilot trial where warfarin patients using the patch stayed in range 30% more of the time. The conversation ends on the long road from prototype to pharmacy shelf, with a nod to the FDA clearance pathway for these novel diagnostic devices. No fluff, one concrete case, real science. #WearableTech #DrugMonitoring #Biolinq #StanfordResearch #LithiumTherapy #Warfarin #ContinuousMonitoring #InterstitialFluid #PersonalizedDosing #FDA #ClinicalTrials #ElectrochemicalSensor #BipolarDisorder #TechPodcast #FexingoBusiness #BusinessPodcast #Biotech #MedicalDevices Keep every episode free: buymeacoffee.com/fexingo